Entry criteria for drug trials of irritable bowel syndrome

American Journal of Medicine

Volumn 107, Issue 5 SUPPL. 1, 1999, Pages 51-58

  Kamm, Michael A ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CISAPRIDE; LOPERAMIDE; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT;

ANXIETY; CLINICAL PROTOCOL; CONSTIPATION; DEPRESSION; DIARRHEA; HUMAN; IRRITABLE COLON; NOCICEPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; SEXUAL ABUSE; SYMPTOM;

EID: 0032740096     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00079-0     Document Type: Article

References (40)

1. Agreus L., Talley N.J., Svardsudd K., Nyren O., Tibblin G., Jones M.P. Is it possible to simplify the definition of the irritable bowel syndrome in population-based studies and clinical practice. Gastroenterology. 114:1998;A2.
2. Kline K.B. Controlled treatment trials in the irritable bowel syndrome a critique . Gastroenterology. 95:1988;232-241.
3. Manning A.P., Thompson W.G., Heaton K.W., Morris A.F. Towards a positive diagnosis of the irritable bowel syndrome. BMJ. 2:1978;653-654.
4. Thompson W.G. Gastrointestinal symptoms in the irritable bowel syndrome compared with peptic ulcer and inflammatory bowel disease. Gut. 25:1984;1089-1092.
5. Kapoor K.K., Wigom P., Rastogi C.K., Kumar A., Gupta A.K. Clinical profile of irritable bowel syndrome. Indian J Gastroenterol. 4:1985;15-16.
6. Talley N.J., Phillips S.J., Melton L.J., Mulvihill C., Wiltgen C., Zinsmeister A.R. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 31:1990;77-81.
7. Poynard T., Couturier D., Frexinos J., et al. French experience of Manning's criteria in the irritable bowel syndrome. Eur J Gastroenterol Hepatol. 4:1992;747-752.
8. Taub E., Cuevas J.L., Cook E.W., Crowell M., Whitehead W.E. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci. 40:1995;2647-2655.
9. Smith R.C., Greenbaum D.S., Vancouver J.B., et al. Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology. 100:1991;591-595.
10. Talley N.J. Diagnosing irritable bowel syndrome Does sex matter? Gastroenterology. 100:1991;834-837.
11. Thompson W.G. Gender differences in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 9:1997;299-302.
12. Thompson W.G., Creed F., Drossman D.A., Heaton K.W., Mazzacca G. Functional bowel disorders and functional abdominal pain. Gastroenterol Int. 5:1992;75-91.
13. Talley N.J., Weaver A.L., Zinsmeister A.R., Melton L.J. Self-reported diarrhea What does it mean? Am J Gastroenterol. 89:1994;1160-1164.
14. Thompson W.G., Heaton K.W., Smyth G.T., Smyth C. Irritable bowel syndrome the view from general practice . Eur J Gastroenterol Hepatol. 9:1997;689-692.
15. Whitehead W.E., Bosmajian L., Zonderman A.B., Costa P.T., Schuster M.M. Symptoms of psychological distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology. 95:1988;709-714.
16. Smith R.C., Greenbaum D.S., Vancouver J.B., et al. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology. 98:1990;293-301.
17. Drossman D.A., McKee D.C., Sandler R.S., et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 95:1988;701-708.
18. Hahn B.A., Kirchdoerfer L.J., Fullerton S., Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharamacol Ther. 11:1997;553-559.
19. Kettell J., Jones R., Lydiard S. Reasons for consultation in irritable bowel syndrome symptoms and patient characteristics . Br J Gen Pract. 42:1992;359-361.
20. Walker E.A., Katon W.J., Jemelka R.P., Roy-Bryne P.P. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiological Catchment Area (ECA) Study. Am J Med. 91:1992;26S-30S.
21. Fowlie S., Eastwood M.A., Prescott R. Irritable bowel syndrome assessment of psychological disturbance and its influence on the response to fibre supplementation . J Psychosom Res. 32:1992;175-180.
22. Chiotakakou-Faliakou E., Kamm M.A., Roy A.J., Storrie J.B., Turner I.C. Biofeedback provides long term benefit for patients with intractable slow and normal transit constipation. Gut. 42:1998;517-521.
23. Drossman D.A., Leserman J., Nachman G., et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 113:1990;828-833.
24. Talley N.J., Fett S.L., Zinsmeister A.R., Melton L.J. Gastrointestinal tract symptoms and self-reported abuse a population based study . Gastroenterology. 107:1994;1040-1049.
25. Walker E.A., Katon W.J., Roy-Byrne P.P., Jemelka R.P., Russo J. Histories of sexual victimisation in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 150:1993;1502-1506.
26. Dewsnap P., Gomborone J., Libby G., Farthing M. The prevalence of symptoms of irritable bowel syndrome among acute psychiatric inpatients with an affective disorder. Psychosomatics. 37:1996;385-389.
27. Hyams J.S., Burke G., Davis P.M., Rzepski B., Andrulonis P.A. Abdominal pain and irritable bowel syndrome in adolescents a community-based study . J Pediatr. 129:1996;220-226.
28. Lembo T., Fullerton S., Diehl D., et al. Symptom duration in patients with irritable bowel syndrome. Am J Gastroenterol. 91:1996;898-905.
29. Guthrie E.A., Creed F.H., Whorwell P.J., Tomenson B. Outpatients with irritable bowel syndrome a comparison of first time and chronic attenders . Gut. 33:1992;361-363.
30. Francis C.Y., Whorwell P.J. Bran and irritable bowel syndrome. Lancet. 344:1994;39-40.
31. Rees A.G., Trevan M., Davies G.J. Dietary fibre modification and the symptoms of irritable bowel syndrome a review . J Hum Nutr Dietet. 7:1994;179-189.
32. Cook I.J., van Eeden A., Collins S.M. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology. 93:1987;727-733.
33. Mertz H., Naliboff B., Munakata J., Niazi N., Mayer E. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 109:1995;40-52.
34. Aggarwal A., Cutts T.F., Abell T.L., et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 106:1994;945-950.
35. Emmanuel A.V., Kamm M.A. Gastrointestinal mucosal laser Doppler blood flow to measure gut innervation reproducibility and effect of food, diurnal variation, age, body size, menstrual cycle, and gender . Gastroenterology. 112:1997;A729.
36. Emmanuel A.V., Kamm M.A. Laser Doppler mucosal flowmetry the first direct measure of the level of activation of extrinsic nerves to the gut . Gastroenterology. 112:1997;A729.
37. Emmanuel A.V., Kamm M.A. Successful response to biofeedback for constipation is associated with specifically improved extrinsic autonomic innervation to the large bowel. Gastroenterology. 112:1997;A729.
38. Emmanuel A.V., Kamm M.A. Direct evidence of psychological state affecting extrinsic innervation of the gut laser Doppler flowmetry to measure mucosal blood flow . Gastroenterology. 112:1997;A728.
39. Gwee K.A., Graham J.C., McKendrick M.W., et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 347:1996;150-153.
40. Poynard T., Naveau S., Mory B., Chaput J.C. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 8:1994;499-510.